Monoamine oxidase inhibitors (MAOIs) are an important class of drugs prescribed for
treatment of depression and other neurological disorders. Evidence has suggested that …

Synucleinopathies are a group of neurodegenerative disorders caused by the accumulation
of toxic species of α-synuclein. The common clinical features are chronic progressive …

Monoamine oxidase A (MAO-A) is a promising diagnostic marker for cancer, depression,
Parkinson's disease, and liver disease. The fluorescence detection of MAO-A in living …

Background Parkinson's disease (PD), a highly prevalent neuro-motor disorder is caused
due to progressive loss of dopaminergic (DAergic) neurons at substantia nigra region of …

Flavonoids exhibit several biological activities including inhibition of Monoamine oxidase
(MAO), an enzyme that metabolizes several neurotransmitters. Thus, MAO inhibitors are well …

Numerous physiological and pathological roles have been attributed to the formation of
mitochondrial reactive oxygen species (ROS). However, the individual contribution of …

Diabetes leads to cardiomyopathy and heart failure, the leading cause of death for diabetic
patients. Monoamine oxidase (MAO) inhibition in diabetic cardiomyopathy prevents …

Prostate cancer (PCa) is a major cause of mortality and morbidity in men. Available
therapies yield limited outcome. We explored anti-PCa activity in a polyphenol-rich fraction …

This study depicted the effect of IL-13 and 13 (S) HpODE (the endogenous product during IL-
13 activation) in the process of cancer cell apoptosis. We examined the role of both IL-13 …

Parkinson's disease is characterized by its distinct pathological features; loss of dopamine
neurons in the substantia nigra pars compacta and accumulation of Lewy bodies and Lewy …